The CD52 antigen was extracted from human spleens with organic solvent
s and purified by immunoaffinity and reverse-phase chromatography, The
latter step resolved two CD52 species, called CD52-I and CD52-II. Bot
h species were found to contain similar N-linked oligosaccharides and
glycosylphosphatidylinositol (GPI) anchor glycans, The N-linked oligos
accharides were characterized by methylation linkage analysis and, fol
lowing exhaustive neuraminidase and endo-beta-galactosidase digestion,
by the reagent array analysis method TM. The results showed that the
single CD52 N-glycosylation site is occupied by large sialylated, poly
lactosamine-containing, core-fucosylated tetraantennary oligosaccharid
es. The locations of the phosphoryl substituents on the GPI anchor gly
can were determined using a new and sensitive method based upon partia
l acid hydrolysis of the GPI glycan. The difference between CD52-I and
CD52-II was in the phosphatidylinositol (PI) moieties of the GPI anch
ors. The phosphatidylinositol-specific phospholipase C-sensitive CD52-
I contained exclusively distearoyl-PI, while the PI-phospholipase C-re
sistant CD52-II contained predominantly a palmitoylated stearoyl-arach
idonoyl-PI, as judged by electrospray ionization mass spectrometry. Ta
ndem mass spectrometric studies indicated that the palmitoyl residue o
f the CD52-II anchor is attached to the S-position of the myo inositol
ring, Both the CD52-I and CD52-II PI structures are unusual for GPI a
nchors and the possible significance of this is discussed. The alkali-
lability of the CD52 epitope recognized by the Campath-1H monoclonal a
ntibody was studied. The data suggest that the alkali-labile hydroxyes
ter-linked fatty acids of the GPI anchor are necessary for antibody bi
nding.